Stroke
Conditions
Brief summary
This is a single-center randomized control trial assessing the impact of a personalized video-based educational platform on patients satisfaction and stroke knowledge in the context of chronic stroke.
Interventions
BEHAVIORALMyStroke
Personalized video-based stroke education platform
Sponsors
University of Pennsylvania
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. History of ischemic stroke between 1 and 10 years prior to enrollment 2. Receiving outpatient stroke care at the Hospital of the University of Pennsylvania 3. At least 18 years old 4. Access to a smart phone, tablet, or computer 5. Willingness to complete 2 follow-up surveys (7 days and 90 day post-enrollment)
Exclusion criteria
1. Unwilling or unable to access the customized app with a smartphone, tablet, or computer 2. Complete dependence on caregiver for all activities of daily living 3. Stroke occurred less than 1 year or greater than 10 years prior to screening/enrollment 4. Patient has severe aphasia (score of greater than or equal to 2 on National Institutes of Health Stroke Scale item 9)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction with stroke education (90 days) | 90 days | 5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree) |
| Stroke etiology recognition (90 days) | 90 days | The proportion of patients who correctly identify their stroke etiology |
| Stroke risk factor recognition (90 days) | 90 days | The proportion of patients who correctly identify at least one of their vascular risk factors |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Stroke prevention medication recognition (7 days) | 7 days | The proportion of patients who correctly identify their antithrombotic medications |
| Stroke prevention medication recognition (90 days) | 90 days | The proportion of patients who correctly identify their antithrombotic medications |
| Patient satisfaction with stroke education (7 days) | 7 days | 5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree) |
| Stroke etiology recognition (7 days) | 7 days | The proportion of patients who correctly identify their stroke etiology |
| Stroke risk factor recognition (7 days) | 7 days | The proportion of patients who correctly identify at least one of their vascular risk factors |
| Stroke patient education retention (SPER) survey (7 days) | 7 days | total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge) |
| Stroke patient education retention (SPER) survey (90 days) | 90 days | total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge) |
| EuroQOL - visual analog scale (7 days) | 7 days | patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life) |
| EuroQOL - visual analog scale (90 days) | 90 days | patient-reported quality of life score (scale 0-100; higher score reflects better self-reported quality of life) |
| modified Rankin Scale | 90 days | Ordinal functional disability scale (score 0 - 6) |
| Medication adherence (7 days) | 7 days | total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence) |
| Medication adherence (90 days) | 90 days | total score of the Adherence Estimator (3 question survey; total score 0-36; higher score reflects higher risk of non-adherence) |
Countries
United States
Outcome results
None listed